{
  "trial_id": "NCT02788201",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, hemoglobin levels, leukocyte count, absolute neutrophil count, platelet count, total bilirubin levels, AST/SGOT levels, ALT/SGPT levels, creatinine levels, creatinine clearance, prior chemotherapy regimens, presence of measurable disease, presence of new bone lesions, HIV status, use of contraception, history of brain metastases, history of intercurrent illness, Hepatitis B or C status, pregnancy status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "hemoglobin levels",
        "leukocyte count",
        "absolute neutrophil count",
        "platelet count",
        "total bilirubin levels",
        "AST/SGOT levels",
        "ALT/SGPT levels",
        "creatinine levels",
        "creatinine clearance",
        "prior chemotherapy regimens",
        "presence of measurable disease",
        "presence of new bone lesions",
        "HIV status",
        "use of contraception",
        "history of brain metastases",
        "history of intercurrent illness",
        "Hepatitis B or C status",
        "pregnancy status"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Hemoglobin, Leukocytes, Absolute Neutrophil Count, Platelets, Total Bilirubin, AST/SGOT, ALT/SGPT, Creatinine, Creatinine Clearance, Prior Chemotherapy Regimens, Tumor Measurability, HIV Status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Hemoglobin",
        "Leukocytes",
        "Absolute Neutrophil Count",
        "Platelets",
        "Total Bilirubin",
        "AST/SGOT",
        "ALT/SGPT",
        "Creatinine",
        "Creatinine Clearance",
        "Prior Chemotherapy Regimens",
        "Tumor Measurability",
        "HIV Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Prior Chemotherapy Regimens, Prior Radiation Therapy, Prior Surgery, Tumor Histology, Tumor Grade, Metastatic Sites, Baseline Hemoglobin, Baseline Leukocytes, Baseline Absolute Neutrophil Count, Baseline Platelets, Baseline Total Bilirubin, Baseline AST/SGOT, Baseline ALT/SGPT, Baseline Creatinine, Creatinine Clearance.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Prior Chemotherapy Regimens",
        "Prior Radiation Therapy",
        "Prior Surgery",
        "Tumor Histology",
        "Tumor Grade",
        "Metastatic Sites",
        "Baseline Hemoglobin",
        "Baseline Leukocytes",
        "Baseline Absolute Neutrophil Count",
        "Baseline Platelets",
        "Baseline Total Bilirubin",
        "Baseline AST/SGOT",
        "Baseline ALT/SGPT",
        "Baseline Creatinine",
        "Creatinine Clearance"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, Karnofsky performance score, hemoglobin, leukocytes, absolute neutrophil count, platelets, total bilirubin, AST/SGOT, ALT/SGPT, creatinine, creatinine clearance, number of prior cytotoxic chemotherapy regimens, number of prior lines of therapy, time since last chemotherapy, presence of measurable disease, presence of bone lesions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "Karnofsky performance score",
        "hemoglobin",
        "leukocytes",
        "absolute neutrophil count",
        "platelets",
        "total bilirubin",
        "AST/SGOT",
        "ALT/SGPT",
        "creatinine",
        "creatinine clearance",
        "number of prior cytotoxic chemotherapy regimens",
        "number of prior lines of therapy",
        "time since last chemotherapy",
        "presence of measurable disease",
        "presence of bone lesions"
      ]
    }
  }
}